Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Zeggar

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2018
ReplyJun Wada, Sonia Zeggar
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
ReplyJun Wada, Sonia Zeggar
Frontiers in Immunology|February 12, 2021
Deletion of <i>Mir223</i> Exacerbates Lupus Nephritis by Targeting <i>S1pr1</i> in <i>Fas</i> MiceSumie Hiramatsu-Asano, Katsue Sunahori-Watanabe, Sonia Zeggar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 27, 2018
Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus ModelSonia Zeggar, Katsue S Watanabe, Sanae Teshigawara, et al.
Modern Rheumatology|May 3, 2017
Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositisNoriko Tatebe, Ken-Ei Sada, Yosuke Asano, et al.
Scientific Reports|March 1, 2019
Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cellsSumie Hiramatsu, Katsue S Watanabe, Sonia Zeggar, et al.
Acta Medica Okayama|October 19, 2017
Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF TherapyEri Katsuyama, Hiroshi Wakabayashi, Ken-Ei Sada, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2017
Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/<i>lpr</i> Lupus-Prone MiceHaruki Watanabe, Katsue S Watanabe, Keyue Liu, et al.
Modern Rheumatology|November 17, 2016
Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agentsTakayuki Katsuyama, Ken-Ei Sada, Minglu Yan, et al.
Internal Medicine (Tokyo, Japan)|July 5, 2017
Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated VasculitisMichiko Morishita, Haruki Watanabe, Minglu Yan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2018
ReplyJun Wada, Sonia Zeggar
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
ReplyJun Wada, Sonia Zeggar
Frontiers in Immunology|February 12, 2021
Deletion of <i>Mir223</i> Exacerbates Lupus Nephritis by Targeting <i>S1pr1</i> in <i>Fas</i> MiceSumie Hiramatsu-Asano, Katsue Sunahori-Watanabe, Sonia Zeggar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 27, 2018
Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus ModelSonia Zeggar, Katsue S Watanabe, Sanae Teshigawara, et al.
Modern Rheumatology|May 3, 2017
Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositisNoriko Tatebe, Ken-Ei Sada, Yosuke Asano, et al.
Scientific Reports|March 1, 2019
Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cellsSumie Hiramatsu, Katsue S Watanabe, Sonia Zeggar, et al.
Acta Medica Okayama|October 19, 2017
Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF TherapyEri Katsuyama, Hiroshi Wakabayashi, Ken-Ei Sada, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2017
Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/<i>lpr</i> Lupus-Prone MiceHaruki Watanabe, Katsue S Watanabe, Keyue Liu, et al.
Modern Rheumatology|November 17, 2016
Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agentsTakayuki Katsuyama, Ken-Ei Sada, Minglu Yan, et al.
Internal Medicine (Tokyo, Japan)|July 5, 2017
Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated VasculitisMichiko Morishita, Haruki Watanabe, Minglu Yan, et al.
Pageof 2